Skip to main content

Table 3 Genotype frequencies for five p21 SNPs in cervical cancer patients and controls

From: Association of p21 SNPs and risk of cervical cancer among Chinese women

  Patients controls   
  (n=393) (n=434)   
SNP No. (%) No. (%) OR (95% CI) P*
rs762623     
AA 9 (2.3) 16 (3.7) 0.627 (0.272-1.447) 0.274
AG 133 (33.8) 135 (31.1) 1.096(0.816-1.472) 0.542
GG 251 (63.9) 283 (65.2) reference  
rs2395655     
AA 96 (24.4) 92 (21.2) 1.393 (0.936-2.074) 0.102
AG 207 (52.7) 222 (51.2) 1.245 (0.892-1.738) 0.197
GG 90 (22.9) 120 (27.6) reference  
rs1801270     
AA 76 (19.3) 117 (27.0) 0.583(0.399-0.853) 0.005
AC 179 (45.5) 195 (44.9) 0.811 (0.590-1.114) 0.196
CC 138 (35.1) 110 (28.1) reference  
rs3176352     
CC 37 (9.4) 56 (12.9) 0.637 (0.339-1.016) 0.058
CG 177 (45.0) 205 (47.2) 0.883 (0.623-1.114) 0.218
GG 179 (45.5) 173 (39.9) reference  
rs1059234     
CC 131 (33.3) 102 (23.5) 1.392 (0.957-2.023) 0.083
CT 160 (40.7) 221 (50.9) 0.786 (0.560-1.101) 0.161
TT 102 (26.0) 111 (25.6) reference  
  1. * P value was adjusted for age and smoking by multiple logistic regressions. After Bonferroni correction, significant P value was <0.01.